Department of Medicine Archives
Aug. 20, 2014—Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered.
Aug. 7, 2014—An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.
Aug. 1, 2014—Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.
May. 12, 2014—A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.
Apr. 30, 2014—A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
Apr. 25, 2014—Having a “leaky” gut may protect against colitis, a paradoxical finding that alters understanding of the role of cell permeability in intestinal homeostasis and immune regulation.
Apr. 3, 2014—Laura Dugan, M.D., the Larry L. Hillblom Chair in Geriatric Medicine at the University of California San Diego (UCSD), will join the Vanderbilt faculty on April 7 to direct Vanderbilt University’s Division of Geriatric Medicine, a division of the Department of Medicine.
Mar. 27, 2014—A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found.
Feb. 27, 2014—Yale University’s Richard Lifton, M.D., Ph.D., winner of a $3 million, 2014 Breakthrough Prize in Life Sciences for discovering genes and biochemical mechanisms that cause hypertension, will deliver the next Flexner Discovery Lecture March 6.